Grant: BETASTEM THERAPEUTICS INC
Primary Recipient
BETASTEM THERAPEUTICS INC
Amount
$326,697.00
Award Date
9/30/2009
Administering Agency
Health and Human Services, Department of / National Institutes of Health
CDFA Number
93.710
CDFA Program Title
ARRA - Community Services Block Grant
Description
The long term goal is to develop an efficient, safe clinical treatment for diabetic retinopathy using stem cells from the patient's bone marrow or blood that have been activated to repair damaged vessels in the eye. Diabetic retinopathy remains theleading